Ovid Therapeutics (OVID) Shares Issued (2020 - 2025)
Historic Shares Issued for Ovid Therapeutics (OVID) over the last 6 years, with Q3 2025 value amounting to $15000.0.
- Ovid Therapeutics' Shares Issued fell 6052.63% to $15000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $28000.0, marking a year-over-year decrease of 9572.52%. This contributed to the annual value of $622000.0 for FY2024, which is 1626.17% up from last year.
- As of Q3 2025, Ovid Therapeutics' Shares Issued stood at $15000.0, which was down 6052.63% from $13000.0 recorded in Q1 2025.
- Over the past 5 years, Ovid Therapeutics' Shares Issued peaked at $460080.0 during Q3 2021, and registered a low of -$43599.0 during Q4 2022.
- Over the past 5 years, Ovid Therapeutics' median Shares Issued value was $81629.0 (recorded in 2022), while the average stood at $134767.9.
- The largest annual percentage gain for Ovid Therapeutics' Shares Issued in the last 5 years was 41467.7% (2022), contrasted with its biggest fall of 11389.13% (2022).
- Over the past 5 years, Ovid Therapeutics' Shares Issued (Quarter) stood at $313858.0 in 2021, then plummeted by 113.89% to -$43599.0 in 2022, then soared by 175.69% to $33000.0 in 2023, then rose by 15.15% to $38000.0 in 2024, then plummeted by 60.53% to $15000.0 in 2025.
- Its Shares Issued stands at $15000.0 for Q3 2025, versus $13000.0 for Q1 2025 and $38000.0 for Q3 2024.